Bicycle Therapeutics (BCYC) Net Margin (QoQ) (2018 - 2026)
Bicycle Therapeutics (BCYC) Net Margin (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Bicycle Therapeutics | 289.88 Mn | 289.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -681,536.00 |
| Dec 31, 2025 | 46,164.00 |
| Sep 30, 2025 | 220,017.00 |
| Jun 30, 2025 | -209,490.00 |
| Mar 31, 2025 | 78,950.00 |
| Dec 31, 2024 | 49,999.00 |
| Sep 30, 2024 | -147,313.00 |
| Jun 30, 2024 | -16,988.00 |
| Mar 31, 2024 | 66,560.00 |
| Dec 31, 2023 | 1,132.00 |
| Sep 30, 2023 | -55,852.00 |
| Jun 30, 2023 | 42,407.00 |
| Mar 31, 2023 | -44,099.00 |
| Dec 31, 2022 | 57,559.00 |
| Sep 30, 2022 | -42,628.00 |
| Jun 30, 2022 | 20,790.00 |
| Mar 31, 2022 | 41,322.00 |
| Dec 31, 2021 | -78,856.00 |
| Sep 30, 2021 | 66,478.00 |
| Jun 30, 2021 | -10,801.00 |